AB Sciex and University of Melbourne Partner on MS Workflow Studying Biopharmaceutical Metabolism

The technique, which is being developed on AB Sciex's QTRAP 5500 and TripleTOF 5600 machines, could help drugmakers better track the metabolism of their biopharmaceutical agents in vivo, improving studies of their efficacy and safety, said a researcher.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.